Clinical Trials Browser

Terminated × OTHER × quizartinib × Clear all

NCT03735875 2024-09-19

Venetoclax and Quizartinib in Treating Patients With FLT3-mutated Recurrent or Refractory Acute Myeloid Leukemia

Phase 1/2 Terminated

8 enrolled 13 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04209725 2023-12-05

A Study of CPX-351 (Vyxeos™) With Quizartinib for the Treatment of FLT3-ITD Mutation-Positive Acute Myeloid Leukemia

Phase 2 Terminated

1 enrolled 7 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute